| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/31/1994 | US5316934 Prourokinase mutein fused with oligopeptides and fibrin for DNA segments |
| 05/31/1994 | US5316933 Recombinant natural killer cell activator |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316921 Which are resistant to proteolytic cleavage by enzymes capable of in vivo conversion of hgf into it's two chain form |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | US5316919 Genetic engineering; vasodialtors, hypotensive and bronchodilator agents |
| 05/31/1994 | US5316910 Bioassay for influenza A and B nucleoprotein |
| 05/31/1994 | US5316775 Method of treating hepatitis B infection |
| 05/31/1994 | US5316770 Vitamin D derivative feed compositions and methods of use |
| 05/31/1994 | US5316769 Drug for preventing and treating fish diseases |
| 05/31/1994 | US5316766 Thrombosis treatment with fibrinolytics and prostacyclins |
| 05/31/1994 | US5316763 Antitumor |
| 05/31/1994 | US5316754 In vitro assay of mesangial cell-derived receptors for advanced glycosylation endproducts |
| 05/31/1994 | CA2110147A1 Method for treating systemic inflammatory response syndrome |
| 05/28/1994 | CA2110087A1 Stabilised superoxide dismutase (sod) composition |
| 05/26/1994 | WO1994011739A1 Diagnosis of eye disorders |
| 05/26/1994 | WO1994011738A1 Determination of peptide motifs on mhc molecules |
| 05/26/1994 | WO1994011535A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 05/26/1994 | WO1994011525A1 Improved recombinant production of proteins having factor viii:c activity |
| 05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
| 05/26/1994 | WO1994011518A2 Methods for converting a, ab, and b blood types to o blood type |
| 05/26/1994 | WO1994011514A1 Human endogenous retrovirus-k-envelope-gene encoded glycoprotein, and a monoclonal antibody for diagnostic and therapeutic purposes |
| 05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | WO1994011512A2 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | WO1994011510A2 Modulators of hematopoietic progenitor cells |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011508A2 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011503A2 Chimeric factor viii |
| 05/26/1994 | WO1994011502A2 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 05/26/1994 | WO1994011501A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
| 05/26/1994 | WO1994011500A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011498A1 Glycoprotein ligand for p-selectin and methods of use thereof |
| 05/26/1994 | WO1994011497A1 Method of causing selective immunosuppression using hl-60-related lectins |
| 05/26/1994 | WO1994011495A1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 05/26/1994 | WO1994011490A2 Products of the inhibition of advanced glycosylation |
| 05/26/1994 | WO1994011402A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 05/26/1994 | WO1994011401A1 Human homolog of the e-cadherin gene and methods based thereon |
| 05/26/1994 | WO1994011400A1 Peptides from human icam-2 and from human icam-1 and their analogs for use in therapy and diagnosis |
| 05/26/1994 | WO1994011399A1 Specifically crosslinked hemoglobin with free functionality |
| 05/26/1994 | WO1994011398A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 05/26/1994 | WO1994011397A1 Ghrh agonists |
| 05/26/1994 | WO1994011396A1 Ghrh agonists |
| 05/26/1994 | WO1994011395A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011393A1 BICYCLIC GnRH ANTAGONISTS |
| 05/26/1994 | WO1994011392A1 Peptide inhibitors of tyrosine kinases and therapeutic uses thereof |
| 05/26/1994 | WO1994011390A1 Novel pseudodipeptide derivatives, preparation thereof and use thereof as gastrin antagonists |
| 05/26/1994 | WO1994011389A1 Biological mediators of immune functions |
| 05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
| 05/26/1994 | WO1994011045A1 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011028A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011022A1 Use of topically applied factor xiii for inhibiting hemorrhage |
| 05/26/1994 | WO1994011021A1 Bradykinin antagonists |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011018A1 Opioid peptides |
| 05/26/1994 | WO1994011017A1 Orally administrable preparation |
| 05/26/1994 | WO1994011016A1 Specific immune system modulation |
| 05/26/1994 | WO1994011015A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design |
| 05/26/1994 | WO1994011014A1 Compounds that inhibit t cell proliferation and methods using the same |
| 05/26/1994 | WO1994011013A1 Chimeric blood coagulation proteins |
| 05/26/1994 | WO1994011012A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/26/1994 | WO1994011007A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | WO1994010995A1 Antitumour compositions containing taxane derivatives |
| 05/26/1994 | WO1994010980A1 Compositions using microencapsulated neutralizing antibodies |
| 05/26/1994 | WO1994009805A3 Method of treating recurrent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 |
| 05/26/1994 | WO1994009134A3 Modified ciliary neurotrophic factors |
| 05/26/1994 | WO1994008613A3 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | WO1994002510A3 Analogs of pth |
| 05/26/1994 | WO1994001558A3 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | CA2149641A1 Methods for converting a, ab and b blood types to o blood type |
| 05/26/1994 | CA2149515A1 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation |
| 05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | CA2149212A1 Improved recombinant production of proteins having factor viii:c activity |
| 05/26/1994 | CA2149132A1 Specifically crosslinked hemoglobin with free functionality |
| 05/26/1994 | CA2149056A1 Novel polypeptides with opioid receptor activity, nucleic acids encoding these substances and uses thereof |
| 05/26/1994 | CA2149046A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | CA2148945A1 Cyclic compounds linked by a heterocyclic ring useful as inhibitors of platelet glycoprotein iib/iiia |
| 05/26/1994 | CA2148713A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
| 05/26/1994 | CA2148383A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 05/26/1994 | CA2147869A1 Bradykinin antagonists |
| 05/26/1994 | CA2147600A1 Production of human monoclonal antibodies active against hepatitis b surface antigen |
| 05/26/1994 | CA2147503A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/26/1994 | CA2126697A1 Opioid peptides |
| 05/25/1994 | EP0598589A2 Method for the production of proteins in plant fluids |
| 05/25/1994 | EP0598133A1 Remedy for wound |
| 05/25/1994 | EP0598129A1 Novel tetrapeptide derivative |
| 05/25/1994 | EP0598037A1 Buffered formulation of peg-sod |
| 05/25/1994 | EP0598034A1 Production of peptide amides |
| 05/25/1994 | EP0598011A1 Ecdysteroid dependent regulation of genes in mammalian cells |